Diatrizoate Meglumine and Diatrizoate Sodium
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Diatrizoate Meglumine and Diatrizoate Sodium, covering 2022-06-27 to 2023-11-17. Get the full timeline:
Most recent: FDA Approved: DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM — Original Application (Camber Pharmaceuticals, Inc.)